Using an in vivo mouse model of airway inflammation, we showed that Il25-/- mice displayed mitigated inflammatory responses and Th2 responses in HDM-induced asthma model, which was consistent with the previous OVA-induced studies or anti-IL-25 administrated mice model (25, 27). Here, IL25 is linked to asthma.